Nanomedicine Market Research Report Information By Product (Nanoparticles [Metal & Metal Oxide Nanoparticles, Liposomes, Polymers & Polymer-Drug Conjugates, Hydrogel Nanoparticles, Dendrimers], Nanoshells, Nanotubes, and Nanodevices), By Modality (Diagnostics and Treatments), By Application (Drug Delivery, Diagnostic Imaging, Vaccines, Regenerative Medicine, Implants, Biomaterials, and Others) By Indication (Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Neurological Diseases, Oncological Diseases, Anti-Inflammatory Dise

TABLE OF CONTENTS

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Techniques

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Impact on Supply Chain

5.3.3. Impact on Demand

5.3.4. Opportunity and Threat Analysis

6. GLOBAL NANOMEDICINE MARKET, BY PRODUCT

6.1. Overview

6.2. Nanoparticles

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.2.1. Nanoparticles

6.2.2. Liposomes

6.2.3. Polymers & polymer-drug conjugates

6.2.4. Hydrogel nanoparticles

6.2.5. Dendrimers

6.2.6. Inorganic nanoparticles

6.3. Nano-shells

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.4. Nanotubes

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.5. Nanodevices

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

7. GLOBAL NANOMEDICINE MARKET, BY MODALITY

7.1. Overview

7.2. Diagnostics

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

7.3 Treatments

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

8. GLOBAL NANOMEDICINE MARKET, BY APPLICATION

8.1. Overview

8.2. Drug Delivery

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

8.3. Diagnostic Imaging

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

8.4. Vaccines

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

8.5. Regenerative Medicine

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

8.6. Active Implants

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

8.7. Biomaterials

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

8.8. Others

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

9. GLOBAL NANOMEDICINE MARKET, BY INDICATION

9.1. Overview

9.2. Cardiovascular diseases

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

9.3. Infectious Diseases

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

9.4. Orthopedic diseases

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

9.5. Neurological diseases

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

9.6. Oncological diseases

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

9.7. Anti-Inflammatory Disease

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

9.8. Others

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

10. GLOBAL NANOMEDICINE MARKET, BY REGION

10.1. Overview

10.2. North America

10.2.1. US

10.2.2. Canada

10.3. Europe

10.3.1. Germany

10.3.2. France

10.3.3. Italy

10.3.4. Spain

10.3.5. UK

10.3.6. Rest of Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Rest of the World

10.5.1. Middle East & Africa

10.5.2. Latin America

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Nanomedicine Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Global Nanomedicine Market

11.7. Key Developments and Growth Strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial

11.8.1. Sales & Operating Income, 2021

11.8.2. Major Players R&D Expenditure, 2021

12. COMPANY PROFILES

12.1. Pfizer Inc.

12.1.1. Company Overview

12.1.2. Products Offered

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Johnson & Johnson Services, Inc.,

12.2.1. Company Overview

12.2.2. Products Offered

12.2.3. Financial Overview

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. General Electric Company

12.3.1. Company Overview

12.3.2. Products Offered

12.3.3. Financial Overview

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. Invitae Corporation

12.4.1. Company Overview

12.4.2. Products Offered

12.4.3. Financial Overview

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Leadient BioSciences Inc

12.5.1. Company Overview

12.5.2. Products Offered

12.5.3. Financial Overview

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Merck & Co., Inc.

12.6.1. Company Overview

12.6.2. Products Offered

12.6.3. Financial Overview

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. DiaSorin S.p.A.

12.7.1. Company Overview

12.7.2. Products Offered

12.7.3. Financial Overview

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. Nanosphere Health Sciences, Inc.

12.8.1. Company Overview

12.8.2. Products Offered

12.8.3. Financial Overview

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. Celgene Corporation

12.9.1. Company Overview

12.9.2. Products Offered

12.9.3. Financial Overview

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. Teva Pharmaceutical Industries Ltd.

12.10.1. Company Overview

12.10.2. Products Offered

12.10.3. Financial Overview

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL NANOMEDICINE MARKET SYNOPSIS, 2022–2030

TABLE 2 GLOBAL NANOMEDICINE MARKET ESTIMATES & FORECAST, 2022–2030 (USD MILLION)

TABLE 3 GLOBAL NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 4 GLOBAL NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 5 GLOBAL NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 6 GLOBAL NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 7 NORTH AMERICA: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 8 NORTH AMERICA: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 9 NORTH AMERICA: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 10 NORTH AMERICA: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 11 US: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 12 US: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 13 US: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 14 US: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 15 CANADA: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 16 CANADA: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 17 CANADA: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 18 CANADA: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 19 EUROPE: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 20 EUROPE: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 21 EUROPE: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 22 EUROPE: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 23 GERMANY: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 24 GERMANY: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 25 GERMANY: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 26 GERMANY: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 27 UK: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 28 UK: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 29 UK: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 30 UK: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 31 FRANCE: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 32 FRANCE: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 33 FRANCE: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 34 FRANCE: NANOMEDICINE MARKET BY INDICATION, 2022–2030 (USD MILLION)

TABLE 35 ITALY: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 36 ITALY: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 37 ITALY: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 38 ITALY: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 39 SPAIN: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 40 SPAIN: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 41 SPAIN: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 42 SPAIN: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 43 REST OF EUROPE: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 44 REST OF EUROPE: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 45 REST OF EUROPE: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 46 REST OF EUROPE: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 47 ASIA-PACIFIC: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 48 ASIA-PACIFIC: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 49 ASIA-PACIFIC: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 50 ASIA-PACIFIC: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 51 INDIA: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 52 INDIA: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 53 INDIA: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 54 INDIA: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 55 CHINA: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 56 CHINA: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 57 CHINA: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 58 CHINA: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 59 JAPAN: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 60 JAPAN: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 61 JAPAN: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 62 JAPAN: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 63 AUSTRALIA: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 64 AUSTRALIA: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 65 AUSTRALIA: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 66 AUSTRALIA: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 67 SOUTH KOREA: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 68 SOUTH KOREA: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 69 SOUTH KOREA: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 70 SOUTH KOREA: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 71 REST OF ASIA-PACIFIC: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 72 REST OF ASIA-PACIFIC: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 73 REST OF ASIA-PACIFIC: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 74 REST OF ASIA-PACIFIC: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 75 REST OF THE WORLD: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 76 REST OF THE WORLD: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 77 REST OF THE WORLD: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 78 REST OF THE WORLD: GLOBAL NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 79 MIDDLE EAST: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 80 MIDDLE EAST: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 81 MIDDLE EAST: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 82 MIDDLE EAST: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 83 AFRICA: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 84 AFRICA: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 85 AFRICA: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 86 AFRICA: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

TABLE 87 LATIN AMERICA: NANOMEDICINE MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 88 LATIN AMERICA: NANOMEDICINE MARKET, BY MODALITY, 2022–2030 (USD MILLION)

TABLE 89 LATIN AMERICA: NANOMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)

TABLE 90 LATIN AMERICA: NANOMEDICINE MARKET, BY INDICATION, 2022–2030 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL NANOMEDICINE MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL NANOMEDICINE MARKET

FIGURE 4 GLOBAL NANOMEDICINE MARKET SHARE, BY PRODUCT, 2021 (%)

FIGURE 5 GLOBAL NANOMEDICINE MARKET SHARE, BY MODALITY, 2021 (%)

FIGURE 6 GLOBAL NANOMEDICINE MARKET SHARE, BY APPLICATION, 2021(%)

FIGURE 7 GLOBAL NANOMEDICINE MARKET SHARE, BY INDICATION, 2021 (%)

FIGURE 8 GLOBAL NANOMEDICINE MARKET SHARE, BY REGION, 2021 (%)

FIGURE 9 NORTH AMERICA: NANOMEDICINE MARKET SHARE, BY REGION, 2021 (%)

FIGURE 10 EUROPE: NANOMEDICINE MARKET SHARE, BY REGION, 2021 (%)

FIGURE 11 ASIA-PACIFIC: NANOMEDICINE MARKET SHARE, BY REGION, 2021 (%)

FIGURE 12 REST OF THE WORLD: NANOMEDICINE MARKET SHARE, BY REGION, 2021 (%)

FIGURE 13 GLOBAL NANOMEDICINE MARKET: COMPANY SHARE ANALYSIS, 2021 (%)

FIGURE 14 PFIZER INC.: KEY FINANCIALS

FIGURE 15 JOHNSON & JOHNSON SERVICES, INC., KEY FINANCIALS

FIGURE 16 GENERAL ELECTRIC COMPANY.: KEY FINANCIALS

FIGURE 17 INVITAE CORPORATION.: KEY FINANCIALS

FIGURE 18 LEADIENT BIOSCIENCES INC.: KEY FINANCIALS

FIGURE 19 MERCK & CO., INC.: KEY FINANCIALS

FIGURE 20 DIASORIN S.P.A.: KEY FINANCIALS

FIGURE 21 NANOSPHERE HEALTH SCIENCES, INC.: KEY FINANCIALS

FIGURE 22 CELGENE CORPORATION: KEY FINANCIALS

FIGURE 23 TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY FINANCIALS